2854.4500 -25.90 (-0.90%)
NSE Apr 01, 2025 12:22 PM
Volume: 35,391
 

2854.45
-0.90%
Karvy
Revenue growth impacted by GST: Revenues for the quarter at Rs 8163 mn were below our estimates of Rs 8613 mn. The operating margins at 20.2% in Q2FY19 were below our estimates of 24%.
GlaxoSmithKline Phar.. has an average target of 2630.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended